These studies indicate that various features of the tumor microenvironment such as ECM stiffness, NO, and hypoxia, can serve as regulators that increase the expression of RUNX2 and promote tumor growth by resulting in the expression of genes involved in anti-apoptosis, angiogenesis, and proliferation. This evidence concerns the gene RUNX2 and neoplasm.